Vincent Ahonkhai
Director
Infectious Diseases
NAP
India
Biography
VINCENT AHONKHAI, M.D., is Vice President and Director at SmithKline Beecham Pharmaceuticals and is responsible for clinical research and development and medical affairs in anti-infectives and biologicals in North America. He has held this position since 1995, overseeing a product portfolio that includes antibiotics, antivirals, and vaccines. After completing medical school and internships in Nigeria, Dr. Ahonkhai obtained additional training in pediatric residency, followed by a fellowship in infectious diseases in adults and pediatrics at the State University of New York–Downstate Medical Center, Brooklyn, from 1975 to 1980. He then joined the faculty as Assistant Professor, Department of Pediatrics. In 1982, Dr. Ahonkhai started his pharmaceutical industry career as Associate Director, Infectious Diseases, at Merck, where he rose to the director level. Subsequently, he moved to the Robert Wood Johnson Pharmaceutical Research Institute, where he served first as Head of Infectious Diseases and later as Executive Director, Dermatology and Wound Healing. Dr. Ahonkhai is board
Research Interest
VINCENT AHONKHAI, M.D., is Vice President and Director at SmithKline Beecham Pharmaceuticals and is responsible for clinical research and development and medical affairs in anti-infectives and biologicals in North America. He has held this position since 1995, overseeing a product portfolio that includes antibiotics, antivirals, and vaccines. After completing medical school and internships in Nigeria, Dr. Ahonkhai obtained additional training in pediatric residency, followed by a fellowship in infectious diseases in adults and pediatrics at the State University of New York–Downstate Medical Center, Brooklyn, from 1975 to 1980. He then joined the faculty as Assistant Professor, Department of Pediatrics. In 1982, Dr. Ahonkhai started his pharmaceutical industry career as Associate Director, Infectious Diseases, at Merck, where he rose to the director level. Subsequently, he moved to the Robert Wood Johnson Pharmaceutical Research Institute, where he served first as Head of Infectious Diseases and later as Executive Director, Dermatology and Wound Healing. Dr. Ahonkhai is board
